Magnesiocard
Recall
|
Medicines
|
19/03/2013
The marketing authorization holder has informed its supplied customers and medical home pharmacies that a microbiological contamination has been detected in a batch of the drug "Magnesium Verla i.v./i.m. Injection Solution" from Verla-Pharm Arzneimittel GmbH & Co. KG, which is only approved in Germany, was found to be microbiologically contaminated. Since the medicinal product approved in Austria was manufactured in an analogous manufacturing process by the same contract manufacturer, all packages of this medicinal product currently in circulation or in transit are being recalled as a precautionary measure.
| Name of the medicinal product | Magnesiocard i.v. - Ampullen |
|---|---|
| Marketing authorisation number(s) | 1-18609 |
| Marketing authorisation holder | Kwizda Pharma GmbH |
| Batch number(s) | 100001, 110001, 120001 |
| Classification of the recall | 2 |
| BASG reference number | INS-640.001-0692 |
Further inquiry note
Page last modified:
12/07/2022